A carregar...
Incorporating biomarkers to improve statistical power of immunotherapeutic neoadjuvant clinical trials in patients with triple-negative breast cancer
Neoadjuvant (preoperative) approach to breast cancer treatment has become widely accepted. Traditionally the primary objective of neoadjuvant treatment is to improve subsequent surgical intervention and the effectiveness are often evaluated by its ability achieving complete pathological response (pC...
Na minha lista:
| Publicado no: | Stat Biopharm Res |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6714581/ https://ncbi.nlm.nih.gov/pubmed/31467642 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/19466315.2018.1518259 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|